Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: A rat model of post-stroke depression

Psychiatry Research

Volumn 170, Issue 2-3, 2009, Pages 245-251

  Wang, Shao hua ^a   Zhang, Zhi jun ^a   Guo, Yi jing ^a   Teng, Gao jun ^b   Chen, Bao an ^a  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

5 HT1A receptor; Chronic mild stress; Citalopram; Dentate gyrus; Hippocampus; Post stroke depression

Indexed keywords

CITALOPRAM; MESSENGER RNA; SEROTONIN 1A RECEPTOR;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC STRESS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DISEASE MODEL; DRUG EFFECT; DRUG TARGETING; GENE EXPRESSION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONINERGIC TRANSMISSION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; CITALOPRAM; DENTATE GYRUS; DEPRESSION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EXPLORATORY BEHAVIOR; FOOD PREFERENCES; FUNCTIONAL LATERALITY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; STROKE; TIME FACTORS;

EID: 70449553410     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.07.006     Document Type: Article

References (42)

1. Barden N., Reul J.M., and Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?. Trends in Neuroscience 18 (1995) 6-11
2. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Huang Y., Gautier C., and Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46 (1999) 1375-1387
3. Duman R.S., Malberg J., and Thome J. Neural plasticity to stress and antidepressant treatment. Biological Psychiatry 46 (1999) 1181-1191
4. Ferrarese C., Bassi S., Frattola L., Locatelli P., Piolti R., and Trabucchi M. Different patterns of CSF neurotransmitter metabolism in patients with left or right hemispheric stroke. Acta Neurologica Scandinavica 73 (1986) 581-585
5. Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron 25 (2000) 11-14
6. Gould E., Reeves A.J., Graziano M.S., and Gross C.G. Neurogenesis in the neocortex of adult primates. Science 286 (1999) 548-552
7. Hackett M.L., Yapa C., Parag V., and Anderson C.S. Frequency of depression after stroke: a systematic review of observational studies. Stroke 36 (2005) 1330-1340
8. Haddjeri N., Blier P., and de Montigny C. Long-term antidepressant treatments result in a tonic activation of the forebrain 5HT1A receptors. Journal of Neurochemistry 18 (1998) 10150-10160
9. Hall M.D., el Mestikawy S., Emerit M.B., Pichat L., Hamon M., and Gozlan H. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre-and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. Journal of Neurochemistry 44 (1985) 1685-1696
10. Katz R.J., Roth K.A., and Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neuroscience and Biobehavioral Reviews. 5 (1981) 247-251
11. Koizumi J., Yoshida Y., and Nakazawa T. Experimental studies of ischemic brain edema: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Japanese Journal of Stroke 8 (1986) 1-8
12. Kreiss D.S., and Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. Journal of Pharmacology and Experimental Therapeutics 274 (1995) 866-876
13. Lai I.C., Hong C.J., and Tsai S.J. Expression of cAMP response element-binding protein in major depression before and after antidepressant treatment. Neuropsychobiology 48 (2003) 182-185
14. Le Poul E., Boni C., Hanoun N., Laporte A.M., Laaris N., Chauveau J., Hamon M., and Lanfumey L. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 (2000) 110-122
15. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods 25 (2001) 402-408
16. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
17. Lopez-Figueroa A.L., Norton C.S., Lopez-Figueroa M.O., Armellini-Dodel D., Burke S., and Akil H. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biological Psychiatry 55 (2004) 225-233
18. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. Regulation of 5HT1Areceptor, glucocorticoid and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biological Psychiatry 43 (1998) 547-573
19. Lopez J.F., Liberzon I., Vazquez D.M., Young E.A., and Watson S.J. Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress. Biological Psychiatry 45 (1999) 934-937
20. Meijer O.C., and de Kloet E.R. Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. European Journal of Pharmacology 266 (1994) 255-261
21. Meijer O.C., and de Kloet E.R. Corticosterone and 5-HT neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Critical Reviews Neurobiology 12 (1998) 1-20
22. Meltzer H.Y., and Lowy M.T. The serotonin hypothesis of depression. In: Meltzer H.Y. (Ed). Psychopharmacology: The Third Generation of Progress (1987), Raven Press, New York 513-526
23. Mendez J., Kadia T.M., Somayazula R.K., El-Badawi K.I., and Cowen D.S. Differential coupling of serotonin 5-HT1A and 5-HT1B receptors to activation of ERK2 and inhibition of adenylyl cyclase in transfected CHO cells. Journal of Neurochemistry. 73 (1999) 162-168
24. Mongeau R., Blier P., and de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Research Reviews 23 (1997) 145-195
25. Mrsulja B.B., Mrsulja B.J., Spatz M., and Klatzo I. Brain serotonin alter experimental vascular occlusion. Neurology 26 (1976) 785-787
26. Nakagawa S., Kim J.E., and Lee R. CREB plays a critical role in the survival of newborn cells in the adult hippocampus. Society of Neuroscience Abstract 26 (2000) 2317
27. Neumaier J.F., Sexton T.J., Hamblin M.W., and Beck S.G. Corticosteroids regulate 5-HT(1A) but not 5-HT(1B) receptor mRNA in rat hippocampus. Brain Research. Molecular Brain Research 82 (2000) 65-73
28. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 15 (1995) 7539-7547
29. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. Journal of Neuroscience 16 (1996) 2365-2372
30. Papp M., Nalepa I., Antkiewicz-Michaluk L., and Sanchez C. Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model. Pharmacology, Biochemistry, and Behavior 72 (2002) 465-474
31. Raap D.K., Evans S., Garcia F., Li Q., Muma N.A., and Wolf W.A. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. Journal of Pharmacology and Experimental Therapeutics 288 (1999) 98-106
32. Radley J.J., and Jacobs B.L. 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Research 955 (2002) 264-267
33. Robinson R.G., Shoemaker W.J., Schlumpf M., Valk T., and Bloom F.E. Effect of experimental cerebral infarction in rat brain on catecholamines and behavior. Nature 255 (1975) 332-334
34. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., and Meyer J. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Archives of General Psychiatry 57 (2000) 174-180
35. Shen C.P., Tsimberg Y., Salvadore C., and Meller E. Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions. BMC Neuroscience 5 (2004) 36
36. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 22 (2002) 3251-3261
37. Starkstein S.E., Robinson R.G., Berthier M.L., Parikh R.M., and Price T.R. Differential mood changes following basal ganglia versus thalamic lesions. Archives of Neurology 45 (1988) 725-730
38. Stokes P.E. The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. European Neuropsychopharmacology 5 (Suppl. (1995) 77-82
39. Willner P. Chronic Mild Stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52 (2005) 90-110
40. Willner P., Towell A., Sampson D., Sophokleous S., and Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 93 (1987) 358-364
41. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134 (1997) 319-329
42. Yuan J., and Yankner B.A. Apoptosis in the nervous system. Nature 407 (2000) 802-809